Owlet, Inc.
NYSE:OWLTMedical - Devices
+$0.46 today
- Market cap
- $107.24M
- Beta
- 1.86
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$12.67
Volume 0.64M
Average 0.24M
OWLT Total Current Assets
All assets expected to be converted to cash or used up within one year.
Owlet, Inc.NYSE: OWLT
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets rises 70.3% from a year ago
Total current assets stood at $82.45M at the end of Q1 FY2026, up 70.3% from a year earlier and up 0.7% from the prior quarter. Over 3 fiscal years it compounded at +16.9% a year.
Context
- Total current assets amounted to 95.0% of total assets at the end of Q1 FY2026, up 0.8 pp from a year earlier.
- Total current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +70.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 81.9M USD
- Year-over-year change
- +77.6%
- 4-year CAGR
- -11.9%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.9M | +77.6% |
| FY2024 | 2024-12-31 | 46.11M | +15.4% |
| FY2023 | 2023-12-31 | 39.94M | -22.1% |
| FY2022 | 2022-12-31 | 51.26M | -62.3% |
| FY2021 | 2021-12-31 | 135.82M | — |
Total Current Assets vs competitors
How OWLT compares with its peers on the latest reported figures
- OWLT's Mar 2026 total current assets of $82.45M is the 5th highest of the 10 companies compared; the peer median is $49.23M.
- Its year-over-year change of +70.3% is the 2nd highest of 10, against a peer median of -13.8%.
- Total current assets amounts to 95.0% of total assets for OWLT, versus a peer median of 78.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
AVRAnteris Technologies Global Corp. | Mar 2026 | $286.67M | +441.1% | +8.6% | 97.3% |
| Mar 2026 | $143.57M | +4.5% | +40.5% | 99.4% | |
| Mar 2026 | $122.94M | -21.1% | -22.3% | 63.2% | |
| Mar 2026 | $93.56M | -8.7% | -15.2% | 52.2% | |
| Mar 2026 | $82.45M | +70.3% | +16.9% | 95.0% | |
| Mar 2026 | $49.23M | -28.8% | -23.9% | 78.9% | |
| Mar 2026 | $47.34M | -42.8% | -18.6% | 96.3% | |
| Mar 2026 | $42.4M | -13.8% | +11.5% | 64.0% | |
| Mar 2026 | $31.36M | +13.9% | +15.4% | 92.0% | |
ELTXElicio Therapeutics, Inc. | Mar 2026 | $16.2M | -22.6% | +21.7% | 71.4% |
| Peer median (excluding OWLT) | $49.23M | -13.8% | +8.6% | 78.9% | |
Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 95.05M | 11.23M | 16.56M | 20.25M | 35.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 10.47M | 15.96M | 13.97M | 12.14M | 22.9M |
| Inventory | 17.98M | 18.52M | 6.49M | 10.52M | 15.3M |
| Other Current Assets | 0 | 0 | 1 | 386K | 8.2M |
| Total Current Assets | 135.82M | 51.26M | 39.94M | 46.11M | 81.9M |
| Property, Plant & Equipment (Net) | 1.87M | 3.37M | 1.31M | 240K | 400K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.7M | 2.28M | 2.21M | 975K | 1.4M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 666K | 1.2M | 655K | 2.19M | 1.9M |
| Total Non-current Assets | 4.23M | 6.84M | 4.18M | 3.4M | 3.7M |
| Total Assets | 140.05M | 58.1M | 44.12M | 49.52M | 85.6M |
| Account Payables | 27.77M | 30.43M | 13.68M | 11.28M | 12M |
| Short-term Debt | 8.53M | 15.04M | 15.19M | 7.37M | 10.57M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.06M | 0 | 0 | 0 | 2.3M |
| Other Current Liabilities | 0 | 8.62M | 4.09M | 2.31M | (94K) |
| Total Current Liabilities | 69.09M | 66.6M | 45.09M | 36.43M | 44.2M |
| Long-term Debt | 7.99M | 0 | 0 | 4.33M | 2.46M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 7.77M | 975K | 28.69M | 29.82M | 3.47M |
| Total Non-current Liabilities | 15.77M | 2.14M | 28.71M | 34.23M | 5.93M |
| Total Liabilities | 84.86M | 68.74M | 73.8M | 70.66M | 50.2M |
| Common Stock | 11K | 1K | 1K | 2K | 3K |
| Retained Earnings | (143.42M) | (222.76M) | (255.66M) | (268.2M) | (307.87M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 55.19M | (10.64M) | (29.68M) | (21.15M) | 35.4M |
| Total Debt | 16.53M | 18.31M | 16.39M | 11.87M | 13.03M |
| Net Debt | (78.53M) | 7.07M | (172K) | (8.38M) | (22.47M) |
Owlet, Inc.
NYSE:OWLT
Intrinsic Alpha fair value
Locked
Current Price
$3.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.